Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.010
-0.040 (-1.95%)
Apr 15, 2026, 4:26 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 11.25 million as of April 15, 2026. Its market cap has increased by 167.59% in one year.
Market Cap
11.25M
Enterprise Value
10.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.01
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 11.25M, a decrease of -66.56%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 11.25M | 23.20% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 24.92M |
| Sareum Holdings | 23.47M |
| Aptamer Group | 18.29M |
| Fusion Antibodies | 17.50M |
| Cizzle Biotechnology Holdings | 9.32M |
| Oxford BioDynamics | 8.15M |
| Futura Medical | 6.92M |
| IXICO | 6.83M |